Hillary Tsang

Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG

E. Perlstein, E. Morava, Nina DiPrimio, 2019, Disease Models & Mechanisms.

Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG

E. Perlstein, E. Morava, Nina DiPrimio, 2019, Disease Models & Mechanisms.

Multi-Species Phenotypic Screening across Disease Models of Mucolipidosis Type IV

Nathan T. Ross, Stephen M. Canham, John A. Tallarico, 2021, bioRxiv.

Drug screens of NGLY1 deficiency in worm and fly models reveal catecholamine, NRF2 and anti-inflammatory-pathway activation as potential clinical approaches

E. Perlstein, Nina DiPrimio, Feba S Sam, 2019, Disease Models & Mechanisms.

Drug screens of NGLY1 deficiency in worm and fly models reveal catecholamine, NRF2 and anti-inflammatory-pathway activation as potential clinical approaches

E. Perlstein, Nina DiPrimio, Feba S Sam, 2019, Disease Models & Mechanisms.